Julianti, E.; Abrian, I.A.; Wibowo, M.S.; Azhari, M.; Tsurayya, N.; Izzati, F.; Juanssilfero, A.B.; Bayu, A.; Rahmawati, S.I.; Putra, M.Y.
Secondary Metabolites from Marine-Derived Fungi and Actinobacteria as Potential Sources of Novel Colorectal Cancer Drugs. Mar. Drugs 2022, 20, 67.
https://doi.org/10.3390/md20010067
AMA Style
Julianti E, Abrian IA, Wibowo MS, Azhari M, Tsurayya N, Izzati F, Juanssilfero AB, Bayu A, Rahmawati SI, Putra MY.
Secondary Metabolites from Marine-Derived Fungi and Actinobacteria as Potential Sources of Novel Colorectal Cancer Drugs. Marine Drugs. 2022; 20(1):67.
https://doi.org/10.3390/md20010067
Chicago/Turabian Style
Julianti, Elin, Ikram Ammar Abrian, Marlia Singgih Wibowo, Muhammad Azhari, Nadya Tsurayya, Fauzia Izzati, Ario Betha Juanssilfero, Asep Bayu, Siti Irma Rahmawati, and Masteria Yunovilsa Putra.
2022. "Secondary Metabolites from Marine-Derived Fungi and Actinobacteria as Potential Sources of Novel Colorectal Cancer Drugs" Marine Drugs 20, no. 1: 67.
https://doi.org/10.3390/md20010067
APA Style
Julianti, E., Abrian, I. A., Wibowo, M. S., Azhari, M., Tsurayya, N., Izzati, F., Juanssilfero, A. B., Bayu, A., Rahmawati, S. I., & Putra, M. Y.
(2022). Secondary Metabolites from Marine-Derived Fungi and Actinobacteria as Potential Sources of Novel Colorectal Cancer Drugs. Marine Drugs, 20(1), 67.
https://doi.org/10.3390/md20010067
